Katie Twigger

1.6k total citations
18 papers, 1.2k citations indexed

About

Katie Twigger is a scholar working on Genetics, Infectious Diseases and Biotechnology. According to data from OpenAlex, Katie Twigger has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Infectious Diseases and 7 papers in Biotechnology. Recurrent topics in Katie Twigger's work include Virus-based gene therapy research (16 papers), Viral gastroenteritis research and epidemiology (15 papers) and Cancer Research and Treatments (7 papers). Katie Twigger is often cited by papers focused on Virus-based gene therapy research (16 papers), Viral gastroenteritis research and epidemiology (15 papers) and Cancer Research and Treatments (7 papers). Katie Twigger collaborates with scholars based in United Kingdom, United States and Canada. Katie Twigger's co-authors include Kevin J. Harrington, Alan Melcher, Richard G. Vile, Matt Coffey, Hardev Pandha, Johann S. de Bono, Christine L. White, Victoria Roulstone, Laura Vidal and Fiona Errington‐Mais and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Katie Twigger

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Twigger United Kingdom 13 1.1k 571 550 399 352 18 1.2k
Victoria Roulstone United Kingdom 21 980 0.9× 698 1.2× 385 0.7× 425 1.1× 290 0.8× 34 1.3k
Brad Thompson Canada 10 694 0.7× 396 0.7× 319 0.6× 326 0.8× 204 0.6× 24 869
Diana J.M. van den Wollenberg Netherlands 20 1.0k 0.9× 424 0.7× 441 0.8× 640 1.6× 182 0.5× 39 1.3k
Carolina S. Ilkow Canada 17 660 0.6× 585 1.0× 231 0.4× 509 1.3× 160 0.5× 41 1.2k
Jennifer M Paterson Canada 5 956 0.9× 521 0.9× 232 0.4× 447 1.1× 151 0.4× 6 1.2k
Sandra Nishikawa Canada 13 615 0.6× 212 0.4× 334 0.6× 276 0.7× 185 0.5× 18 815
Sascha Bossow Germany 16 763 0.7× 421 0.7× 210 0.4× 388 1.0× 120 0.3× 32 1.1k
Christine E. Engeland Germany 18 792 0.7× 674 1.2× 178 0.3× 385 1.0× 125 0.4× 38 1.1k
Xinping Fu United States 19 664 0.6× 478 0.8× 204 0.4× 490 1.2× 76 0.2× 32 1.0k
Oliver Ebert Germany 24 1.0k 1.0× 549 1.0× 224 0.4× 424 1.1× 112 0.3× 50 1.5k

Countries citing papers authored by Katie Twigger

Since Specialization
Citations

This map shows the geographic impact of Katie Twigger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Twigger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Twigger more than expected).

Fields of papers citing papers by Katie Twigger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Twigger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Twigger. The network helps show where Katie Twigger may publish in the future.

Co-authorship network of co-authors of Katie Twigger

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Twigger. A scholar is included among the top collaborators of Katie Twigger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Twigger. Katie Twigger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Roulstone, Victoria, David Mansfield, R. J. C. Harris, et al.. (2021). Antiviral antibody responses to systemic administration of an oncolytic RNA virus: the impact of standard concomitant anticancer chemotherapies. Journal for ImmunoTherapy of Cancer. 9(7). e002673–e002673. 10 indexed citations
2.
Twigger, Katie, Aileen Rowan, Aidan MacNamara, et al.. (2014). Frequency and function of KIR+ CD8+ T cells in HTLV-1 infection. Retrovirology. 11(S1). 1 indexed citations
3.
Karapanagiotou, Eleni, Victoria Roulstone, Katie Twigger, et al.. (2012). Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies. Clinical Cancer Research. 18(7). 2080–2089. 151 indexed citations
4.
Twigger, Katie, Victoria Roulstone, Joan Kyula, et al.. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer. 12(1). 368–368. 46 indexed citations
5.
Roulstone, Victoria, Katie Twigger, S. Zaidi, et al.. (2012). Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy. Gene Therapy. 20(5). 521–528. 48 indexed citations
6.
Harrington, Kevin J., Eleni Karapanagiotou, Victoria Roulstone, et al.. (2010). Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers. Clinical Cancer Research. 16(11). 3067–3077. 94 indexed citations
7.
Hitchen, Paul G., et al.. (2010). Glycoproteomics: a powerful tool for characterizing the diverse glycoforms of bacterial pilins and flagellins. Biochemical Society Transactions. 38(5). 1307–1313. 18 indexed citations
8.
Lolkema, Martijn P., Hendrik‐Tobias Arkenau, Kevin J. Harrington, et al.. (2010). A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer. Clinical Cancer Research. 17(3). 581–588. 98 indexed citations
9.
Comins, Charles, James Spicer, Andrew Protheroe, et al.. (2010). REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer. Clinical Cancer Research. 16(22). 5564–5572. 109 indexed citations
10.
Twigger, Katie, Laura Vidal, Christine L. White, et al.. (2008). Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy. Clinical Cancer Research. 14(3). 912–923. 88 indexed citations
11.
Errington‐Mais, Fiona, Charles L. White, Katie Twigger, et al.. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Therapy. 15(18). 1257–1270. 86 indexed citations
12.
White, Charles L., Katie Twigger, Laura Vidal, et al.. (2008). Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Therapy. 15(12). 911–920. 124 indexed citations
13.
Qiao, Jian, Timothy Kottke, Christine L. White, et al.. (2008). Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus. Clinical Cancer Research. 14(1). 259–269. 151 indexed citations
14.
Vidal, Laura, Hardev Pandha, Timothy A. Yap, et al.. (2008). A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer. Clinical Cancer Research. 14(21). 7127–7137. 184 indexed citations
15.
Karavasilis, Vasilios, Katie Twigger, Christine White, et al.. (2007). Phase I trial of intratumoral administration of reovirus type 3 with radiation in patients with advanced malignancies. Journal of Clinical Oncology. 25(18_suppl). 14009–14009. 3 indexed citations
16.
Vidal, Laura, Alan Melcher, Kate Newbold, et al.. (2007). A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies.. Molecular Cancer Therapeutics. 6. 5 indexed citations
17.
White, Christine L., Katie Twigger, Peter F. Searle, et al.. (2007). Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo. Gene Therapy. 15(6). 424–433. 15 indexed citations
18.
Vidal, Laura, Timothy A. Yap, Charles L. White, et al.. (2006). Reovirus and other oncolytic viruses for the targeted treatment of cancer. Targeted Oncology. 1(3). 130–150. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Roulstone Breakdown of academic impact, for papers by Brad Thompson Breakdown of academic impact, for papers by Diana J.M. van den Wollenberg Breakdown of academic impact, for papers by Carolina S. Ilkow Breakdown of academic impact, for papers by Jennifer M Paterson Breakdown of academic impact, for papers by Sandra Nishikawa Breakdown of academic impact, for papers by Sascha Bossow Breakdown of academic impact, for papers by Christine E. Engeland Breakdown of academic impact, for papers by Xinping Fu Breakdown of academic impact, for papers by Oliver Ebert
Rankless by CCL
2026